Vira Regen Competitors and Similar CompaniesClear all
Vira Regen's competitors and similar companies include Pharmacyclics, Ascendis Pharma, Exelixis and Genentech.
 Vira Regen Vira Regen is a regenerative biotech company that specializes in gene-specific electroceuticals. |  Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. |  Ascendis Pharma Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology. |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | ||
Founding Date | Founding Date 2023 | Founding Date 1991 | Founding Date 2007 | Founding Date 1994 | Founding Date 1976 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Salt Lake City, US HQ | Locations Sunnyvale, US HQ | Locations Hellerup, DK HQ Heidelberg, DE Palo Alto, US | Locations Alameda, US HQ | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more |
Employees | Employees 3 | Employees 6551% decrease | Employees 1,017 | Employees 1,14712% decrease | Employees 18,077 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 7.7 b | Valuation ($) 8.2 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $729.7m (FY, 2014) | Revenue (est.) €720.1m (FY, 2025) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $40.4m (FY, 2014) | Cost of goods €93.1m (FY, 2025) | Cost of goods $83.7m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $689.3m (FY, 2014) | Gross profit €627.1m (FY, 2025) | Gross profit $2.2b (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income $86.1m (FY, 2014) | Net income (€228m) (FY, 2025) | Net income $782.6m (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Pharmacyclics
HQ
Sunnyvale, US
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
View companyAscendis Pharma
HQ
Hellerup, DK
Employees
1,017
Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology.
View company
Exelixis
HQ
Alameda, US
Employees
1,147↓ 12% decrease
Exelixis is an oncology company that develops cancer treatments.
View companyGenentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View company